Publications by authors named "Rongping Guo"

Claim this Profile
S
Spatial single-cell proteomics landscape decodes the tumor microenvironmental ecosystem of intrahepatic cholangiocarcinoma.
Libing Hong, Jie Mei, Xuqi Sun, Yifan Wu, Zhen Dong, Rongping Guo

Hepatology· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition).
Jian Zhou, Huichuan Sun, Zheng Wang, Wenming Cong, Mengsu Zeng, Guohong Han, Jinhe Guo, Rongping Guo, Wengzhi Guo, Yabing Guo, Guoyue Lv, Guoming Shi

Liver Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The INSPECTOR study: enhanced feasibility for clinical translation of a multi-cancer early detection method based on enzyme-assisted high signal-to-noise ratio sequencing of methylated circulating tumor DNA.
Hui-Yan Luo, Wei Wei, Pansong Li, Qi-Hua Zhang, Zhipeng Zhou, Rong-Ping Guo

Cancer Commun (Lond)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant medication use and clinical outcome in hepatocellular carcinoma treated with immune-based therapy: a multicenter analysis.
Jun-Zhe Yi, Jie Xu, Jiang-Zheng Zeng, Yu-Jia Song, Yu-Nan Zhang, Rong-Ping Guo

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced formation of tertiary lymphoid structures shapes the anti-tumor microenvironment in hepatocellular carcinoma after FOLFOX-HAIC therapy.
Rui Xing, Jie Mei, Zhijun Zuo, Hao Zou, Xingjuan Yu, Rongping Guo

Cell Rep Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic arterial interventional therapies alone or in combination with molecular targeted therapies and PD-(L)1 inhibitors in locally aggressive, early recurrent hepatocellular carcinoma: a retrospective study.
Weixin Luo, Lixuan Liu, Wenping Lin, Jie Mei, Yansong Lin, Rongping Guo

Front Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes of Transarterial Chemoembolization plus Ablation versus Surgical Resection in Patients with Large BCLC Stage A/B HCC.
Ying-Wen Hou, Tian-Qi Zhang, Li-Di Ma, Yi-Quan Jiang, Xue Han, Rong-Ping Guo

Acad Radiol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio in Patients with Hepatocellular Carcinoma Receiving HAIC-Based Conversion Hepatectomy: A Dual-Center Retrospective Cohort Study.
Dong Li, Youwen Fan, Benyi He, Yajun Tang, Gang Deng, Rongping Guo

J Inflamm Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinoma.
Zehao Zheng, Renguo Guan, Rongce Zhao, Junyu Gan, Xinhao Xiong, Rongping Guo

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxaliplatin induces pyroptosis in hepatoma cells and enhances antitumor immunity against hepatocellular carcinoma.
Min Deng, Rongce Zhao, Hao Zou, Renguo Guan, Jiongliang Wang, Rongping Guo

Br J Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transarterial chemoembolization versus hepatic arterial infusion chemotherapy as first treatment for hepatocellular carcinoma with macrovascular invasion.
Benyi He, Min Deng, Shaohua Li, Jie Mei, Lianghe Lu, Rongping Guo

Int J Med Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging-based surrogate classification for risk stratification of hepatocellular carcinoma with microvascular invasion to adjuvant hepatic arterial infusion chemotherapy: a multicenter retrospective study.
Lidi Ma, Cheng Zhang, Yuhua Wen, Kaili Xing, Shaohua Li, Rongping Guo

Int J Surg· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic arterial infusion chemotherapy-based conversion hepatectomy in responders versus nonresponders with hepatocellular carcinoma: a multicenter cohort study.
Min Deng, Chong Zhong, Dong Li, Renguo Guan, Carol Lee, Rongping Guo

Int J Surg· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma.
Shaohua Li, Jie Mei, Rongce Zhao, Jing Zhou, Qiaoxuan Wang, Rongping Guo

Front Immunol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFOX-Based Hepatic Arterial Infusion Chemotherapy with Sequential Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Large Hepatocellular Carcinoma: A Single-Center Retrospective Cohort Study.
Rongce Zhao, Jing Zhou, Zehao Zheng, Xinhao Xiong, Qiaoxuan Wang, Rongping Guo

J Hepatocell Carcinoma· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic arterial infusion chemotherapy in combination with lenvatinib and durvalumab versus standard first-line treatment gemcitabine and cisplatin plus durvalumab in advanced intrahepatic cholangiocarcinoma.
Rongce Zhao, Jing Zhou, Xinhao Xiong, Qiaoxuan Wang, Chunxiao Liu, Rongping Guo

Am J Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ARH score, a practical guide to decision-making for retreatment with hepatic arterial infusion chemotherapy in hepatocellular carcinoma patients.
Jie Mei, Chengyou Yu, Feng Shi, Renguo Guan, Shaohua Li, Rongping Guo

Int Immunopharmacol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with hepatocellular carcinoma extrahepatic metastases can benefit from hepatic arterial infusion chemotherapy combined with lenvatinib plus programmed death-1 inhibitors.
Renguo Guan, Nan Zhang, Min Deng, Ye Lin, Guanjie Huang, Rongping Guo

Int J Surg· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel liver-function-indicators-based prognosis signature for patients with hepatocellular carcinoma treated with anti-programmed cell death-1 therapy.
Zehao Zheng, Jie Mei, Renguo Guan, Jiqi Zhang, Xinhao Xiong, Rongping Guo

Cancer Immunol Immunother· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line hepatic arterial infusion chemotherapy plus lenvatinib and PD-(L)1 inhibitors versus systemic chemotherapy alone or with PD-(L)1 inhibitors in unresectable intrahepatic cholangiocarcinoma.
Yan-Song Lin, Shuo Li, Xia Yang, Rong-Ping Guo, Yu-Hua Huang

J Cancer Res Clin Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lenvatinib plus durvalumab combined with hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinoma.
Rongce Zhao, Jing Zhou, Zhaoxia Miao, Xinhao Xiong, Wei Wei, Rongping Guo

Front Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis.
Yuhua Wen, Lianghe Lu, Jie Mei, Yihong Ling, Renguo Guan, Rongping Guo

J Hepatocell Carcinoma· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vessels encapsulating tumor clusters: a novel efficacy predictor of hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma.
Wenping Lin, Lianghe Lu, Rongliang Zheng, Shasha Yuan, Shaohua Li, Rongping Guo

J Cancer Res Clin Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic arterial infusion chemotherapy versus transarterial chemoembolization, potential conversion therapies for single huge hepatocellular carcinoma: a retrospective comparison study.
Min Deng, Hao Cai, Benyi He, Renguo Guan, Carol Lee, Rongping Guo

Int J Surg· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy.
Min Deng, Rongce Zhao, Renguo Guan, Shaohua Li, Zhijun Zuo, Rongping Guo

Eur J Med Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis